Mega Opposition alliance filled with 'hollow' people with no ideology: Yogendra Yadav

Agencies
January 21, 2019

Kolkata, Jan 21: Casting apprehensions on the agenda of the grand alliance stitched together by opposition parties, Swaraj India president Yogendra Yadav on Sunday said the 'Mahagathbandhan' is a "big joke" and filled with "hollow people" with no ideology.

He said all the leaders in the grand alliance, who are portraying themselves as anti-BJP or anti-Modi (Prime Minister Narendra Modi), were equally anti-democracy and corrupt.

"There was a huge gathering (in Kolkata). But, where is the ideology? What is your agenda. There was no discussion on that. You had no talks on the problems the farmers are facing, and on unemployment. I believe this coalition lacks vision," Yadav said agency.

The politician-activist was referring to Saturday's mega rally organised by the Trinamool Congress in Kolkata, where leaders from over a dozen opposition parties came together, vowing to put up a united fight in the upcoming Lok Sabha elections and oust Modi from power.

"They are saying that Narendra Modi is anti-democracy, but what about (West Bengal Chief Minister) Mamata Banerjee? She is also the same. She has not allowed the panchayat elections to take place peacefully. She does not allow the opposition to host any rally here. You are carrying out rowdyism in your state."

"And (NCP leader) Sharad Pawar, (SP chief) Akhilesh Yadav and (BSP chief) Mayawati all are claiming of saving the country from corruption. This is a big joke. This grand alliance is full of hollow people," he said.

Yadav said the grand alliance is only an opposition but not an alternative to the BJP government at the Centre.

"The country at the moment requires an alternate government instead of opposition. I think national politics is under threat," he said.

The former Aam Aadmi Party (AAP) leader wondered where were the leaders of the 'Mahagathbandhan' in the last five years, when there were many incidents of farmer suicides and movements organised by unemployed youths.

"These politicians were sitting in Parliament all these years, while the struggles were led by farmers, youths and dalit organisations. They are the ones who fought on the streets. We need to form their (farmers, youths) coalition," he said.

Yadav said his party is focusing on coming up with an alternative of a strong opposition by the people against the government.

"People have to build up a strong opposition against the current government, which can be sustained for a long time. We are trying to build that alternative. We need a coalition of social movement," he said.

Launching Swaraj India's '#iCan19' - Indian Citizens' Action for Nation, 2019 - an initiative for citizens to intervene in electoral politics, Yadav said he is hopeful that his party would have an effect on the electoral process.

"We have no capacity of fighting hundreds of seats. We would make a very limited intervention in a select few seats. That is our effort," Yadav added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 27,2020

Kolkata, Jan 27: The West Bengal government on Monday tabled a resolution against the Citizenship (Amendment) Act in the Assembly.

The resolution appeals to the Union government to repeal the amended citizenship law and revoke plans to implement NRC and update NPR.

As per reports, state Parliamentary Affairs Minister Partha Chatterjee introduced the resolution in the House around 2 pm.

Three states - Kerala, Rajasthan and Punjab - have already passed resolutions against the new citizenship law.

The law has emerged as the latest flashpoint in the state, with the TMC opposing the contentious legislation tooth and nail, and the BJP pressing for its implementation.

The new citizenship law has emerged as the latest flashpoint in the state, with the TMC opposing the contentious legislation tooth and nail, and the BJP pressing for its implementation.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 22,2020

New Delhi, Apr 22: Prime Minister Narendra Modi on Wednesday said that The Epidemic Diseases (Amendment) Ordinance, 2020, manifests his government's commitment to protecting healthcare workers braving COVID-19 on the frontline.
"The Epidemic Diseases (Amendment) Ordinance, 2020, manifests our commitment to protect each and every healthcare worker, who is bravely battling COVID-19 on the frontline. It will ensure the safety of our professionals. There can be no compromise on their safety!," Prime Minister Modi tweeted.
The Central government on Wednesday brought an ordinance to end the violence against health workers, making it a cognizable, non-bailable offence with the imprisonment of up to seven years for those found guilty.

"We have brought an ordinance under which any attack on health workers will be a cognizable, non-bailable offence. In the case of grievous injuries, the accused can be sentenced from 6 months to 7 years. They can be penalised from Rs 1 lakh to Rs 5 lakh," Union Minister Prakash Javadekar briefed media after the meeting of the Cabinet.

"Such crime will now be cognisable and non-bailable. An investigation will be done within 30 days. Accused can be sentenced from three months to five years, and penalised from Rs 50,000 up to Rs 2 lakh," said Javadekar.

Moreover, if the damage is done to vehicles or clinics of healthcare workers, then a compensation amounting to twice the market value of the damaged property will be taken from the accused, said Javadekar.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.